PubMed ID:
34051936
Public Release Type:
Journal
Publication Year: 2021
Affiliation: NYU Long Island School of Medicine, NYU Langone Hospital-Long Island, Mineola, NY, USA. Electronic address: alan.jacobson@nyulangone.org.; University of Pittsburgh, Pittsburgh, PA, USA.; George Washington University, Biostatistics Center, Rockville, MD, USA.; Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.; University of California San Diego, La Jolla, CA, USA.; Columbia University Irving Medical Center, New York, NY, USA.; George Washington University, Biostatistics Center, Rockville, MD, USA.; George Washington University, Biostatistics Center, Rockville, MD, USA.; Elson S Floyd College of Medicine, Washington State University, Spokane, WA, USA.; Columbia School of Medicine, University of Missouri, Columbia, MO, USA.; Case Western Reserve University, Rainbow Babies and Children's Hospital, Cleveland, OH, USA.; George Washington University, Biostatistics Center, Rockville, MD, USA.
DOI:
https://doi.org/10.1016/S2213-8587(21)00086-3
Authors:
Jacobson Alan M, Ryan Christopher M, Braffett Barbara H, Gubitosi-Klug Rose A, Lorenzi Gayle M, Luchsinger José A, Trapani Victoria R, Bebu Ionut, Chaytor Naomi, Hitt Susan M, Farrell Kaleigh, Lachin John M
Request IDs:
21938
Studies:
Diabetes Control and Complications Trial / Epidemiology of Diabetes Interventions and Complications
With improved treatment, individuals with type 1 diabetes are living longer but there is limited information on the effects of type 1 diabetes on cognitive ability as they become older adults. We followed up individuals with type 1 diabetes to identify independent risk factors for cognitive decline as people age.